Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

High Priced U.S. Generic Drugs Are Often More Expensive Than Brand Name Counterparts in Other Countries, According to a New Price Analysis by PharmacyChecker.com
  • USA - English


News provided by

PharmacyChecker.com

Nov 20, 2014, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Verified online pharmacies and prescription savings
Verified online pharmacies and prescription savings

White Plains, NY (PRWEB) November 20, 2014 -- As the Senate prepares to hold a hearing about the increasing costs of many generic drugs, PharmacyChecker.com released new data showing that Americans are paying more for many generics than consumers pay for their brand name counterparts in other countries. PharmacyChecker.com verifies online pharmacies and compares prescription drug prices. Some generics cost close to 20 times more than the prices of brand name equivalents available from other countries.

It might seem too good to be true but the fact is that consumers can and do buy the brand name versions of some of these high-priced generics online from licensed pharmacies in other countries at a discount of about 90%, despite federal prohibitions.

Post this

The hearing, “Why are Some Generic Drugs Skyrocketing in Price,” will be held by the Senate Health, Education, Labor and Pensions Committee’s Subcommittee on Primary Health and Aging on Thursday at 1pm. High drug prices in America are a leading cause of prescription non-adherence. According to the Commonwealth Fund, 50 million Americans did not fill a prescription due to cost in 2012 (Source: S. R. Collins, R. Robertson, T. Garber, and M. M. Doty, “Insuring the Future: Current Trends in Health Coverage and the Effects of Implementing the Affordable Care Act”, The Commonwealth Fund, April 2013).

Tod Cooperman, MD, president of PharmacyChecker.com, said, “Americans should not have to skip prescribed medications, brand or generic, due to cost. As we applaud the senators for seeking to discover why costs are on the rise for generic drugs, we encourage further inquiry into how Americans can afford medications they need but can’t afford today. It might seem too good to be true but the fact is that consumers can and do buy the brand name versions of some of these high-priced generics online from licensed pharmacies in other countries at a discount of about 90%, despite federal prohibitions.”

For example, the cash price for 90 pills of the drug budesonide, which treats asthma and other lung ailments, is $1,625 at a chain pharmacy in New York City. For just $155.70, the brand version, Entocort, marketed by AstraZeneca, can be purchased online from a verified international online pharmacy – a savings of over 90%. The cash price for 90 pills of the anti-depression medication clomipramine is $900 at a U.S. pharmacy in New York City. If purchasing from a verified international online pharmacy, the brand version of clomipramine, Anafranil is $45.90 – a savings of 95%.

See prescription drug price comparisons for 10 expensive U.S. generics and their international brand equivalents. [http://www.pharmacychecker.com/pdf/us_generic_foreign_brand_comparisons.pdf

Higher generic drug prices are often attributed to fewer drug manufacturers competing in the marketplace. The causes of lower competition include supply interruptions when the FDA finds manufacturing problems, consolidation among pharmaceutical companies that make the same drug, or low profitability of certain drug products. In some cases, higher generic drug prices are simply due to arbitrary price increases by retail pharmacies.

Federal law prohibits personal drug importation under most circumstances, but the practice is generally permitted and individuals are never prosecuted, according to the FDA (See http://www.moneytalksnews.com/2013/02/01/is-it-safe-to-use-an-overseas-pharmacy/). Peer reviewed studies have demonstrated the safety of international online pharmacies verified by PharmacyChecker.com.

PharmacyChecker.com was founded by Tod Cooperman, M.D. in 2002 to help consumers safely save money on medication by identifying the lowest drug prices from reputable online pharmacies. PharmacyChecker.com independently checks the credentials of online pharmacies and pharmacy discount cards and provides free and easy online comparisons of drug prices.

For more information, contact Gabriel Levitt, Vice President, PharmacyChecker.com at 718-387-4526 or gabriel(dot)levitt(at)pharmacychecker(dot)com.

Gabriel Levitt, PharmacyChecker.com, (718) 387-4526, [email protected]

Modal title

PharmacyChecker.com Pricing Data. U.S. Generics vs. Foreign Brand Equivalents
View PDF
PharmacyChecker.com Pricing Data. U.S. Generics vs. Foreign Brand Equivalents
PharmacyChecker.com Pricing Data. U.S. Generics vs. Foreign Brand Equivalents

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.